This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.
Lancet (London, England), 358(9288), 1119-23
Citation
Channick, R N; Simonneau, G; Sitbon, O; Robbins, I M; Frost, A; Tapson, V F; Badesch, D B; Roux, S; Rainisio, M; Bodin, F; Rubin, L J. (2001). Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.. Lancet (London, England), 358(9288), 1119-23.